BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6479199)

  • 1. Association of circulating immune complexes with glomerular proteinuria in patients with transitional cell carcinoma of the urinary bladder.
    Skaarup P; Jensenius JC; Brandslund I; Svehag SE; Wolf H
    Eur Urol; 1984; 10(4):249-53. PubMed ID: 6479199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary protein profiles in patients with urothelial bladder tumours.
    Hemmingsen L; Rasmussen F; Skaarup P; Wolf H
    Br J Urol; 1981 Aug; 53(4):324-9. PubMed ID: 7260547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complexes in transitional cell carcinoma.
    Pesce AJ; Phillips TM; Ooi BS; Evans A; Shank RA; Lewis MG
    J Urol; 1980 Apr; 123(4):486-8. PubMed ID: 7365881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between circulating immune complexes and renal disease in New Zealand mice.
    Nakai Y; Yoshida H; Maruyama N; Shirai T; Hamashima Y
    Clin Exp Immunol; 1981 Feb; 43(2):240-5. PubMed ID: 6974065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of bullous pemphigoid and transitional cell carcinoma of the bladder. Demonstration of a circulating factor reactive with basement membrane zone of skin and of bladder carcinoma.
    Tanaka T; Ogino A; Ogura K; Nakagawa K
    Arch Dermatol; 1983 Aug; 119(8):704-5. PubMed ID: 6347090
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating immune complexes in patients with bladder cancer and other malignancies of the urogenital tract.
    Kobayashi K; Umeda T; Akaza H; Niijima T; Aikawa T; Tanimoto K
    Urol Int; 1984; 39(4):232-5. PubMed ID: 6485183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Membranous glomerulonephritis and transitional cell carcinoma, improved proteinuria after each tumor resection].
    Fabbian F; Rizzioli E; Catalano C
    G Ital Nefrol; 2003; 20(1):65-8. PubMed ID: 12647289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of proteinuria and circulating immune complexes in febrile patients.
    Sølling J; Sølling K; Mogensen CE
    Acta Med Scand; 1982; 212(3):167-9. PubMed ID: 6756048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotic syndrome associated with transitional cell carcinoma of the bladder.
    Rapoport J; Kuperman O; Gopas Y; Maor E; Eyal A; Mostovslavski M; Abuful A; Chaimovitz C
    Nephron; 1989; 52(1):36-9. PubMed ID: 2651948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urologic malignancies and progressive systemic sclerosis.
    Angulo JC; Lopez JI; Flores N
    Minerva Urol Nefrol; 1993 Mar; 45(1):19-22. PubMed ID: 8322113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-grade transitional cell carcinoma and melanosis of urinary bladder: case report and review of the literature.
    Sanborn SL; MacLennan G; Cooney MM; Zhou M; Ponsky LE
    Urology; 2009 Apr; 73(4):928.e13-5. PubMed ID: 19056107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria in patients with uroepithelial tumours with special regard to tumour size, clinical staging and grade of malignancy.
    Johansson B; Kistner S
    Scand J Urol Nephrol; 1975; 9(1):45-9. PubMed ID: 1215844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune complexes in urine and serum of patients with bladder cancer.
    Babaian RJ; Watson DA; Jones JM
    J Urol; 1984 Mar; 131(3):463-6. PubMed ID: 6699985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological reaction to bilharzial carcinoma of urinary bladder.
    Aly MA; el-Makhzangy MI; el-Adl M; Essa MH
    J Egypt Soc Parasitol; 1988 Dec; 18(2):697-703. PubMed ID: 3418166
    [No Abstract]   [Full Text] [Related]  

  • 15. Association between HLA antigens and bladder tumors.
    Tokuç R; Akdaş A; Ozerkan K; Remzi D
    Eur Urol; 1987; 13(3):207-9. PubMed ID: 3497040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
    Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
    J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental antigen-antibody complex disease in mice. The role of antibody levels, antibody affinity and circulating antigen-antibody complexes.
    Devey ME; Bleasdale K; Collins M; Steward MW
    Int Arch Allergy Appl Immunol; 1982; 68(1):47-53. PubMed ID: 6210640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of class I histocompatibility antigens in transitional cell carcinoma of the urinary bladder in relation to survival.
    Levin I; Klein T; Goldstein J; Kuperman O; Kanetti J; Klein B
    Cancer; 1991 Dec; 68(12):2591-4. PubMed ID: 1933807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of Malakoplakia and Papillary Urothelial Carcinoma of the Urinary Bladder.
    Lee SL; Teo JK; Lim SK; Salkade HP; Mancer K
    Int J Surg Pathol; 2015 Oct; 23(7):575-8. PubMed ID: 26194600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intra-diverticular urothelial tumors of the bladder].
    Bouchot O; Zerbib M
    Prog Urol; 2002 Nov; 12(5):1109-11. PubMed ID: 12536933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.